Indegene And Amwell Partner To Help Life Science Organizations...
healthcaretechoutlook

Indegene And Amwell Partner To Help Life Science Organizations Offer Quality Care To Patients

Healthcare Tech Outlook | Wednesday, June 29, 2022

The partnership between Indegene and Amwell will enable life sciences businesses to link patients to higher quality care and improve health outcomes.

Fremont, CA: The digital engagement of patients has altered the healthcare industry. Patients are becoming informed and involved in their health journeys. They desire mobile access to customized assistance solutions. Indegene, a provider of technology-driven healthcare solutions, has teamed with Amwell, a leader in digital care delivery. This partnership will assist organizations in the life sciences in connecting patients with higher-quality care and improving health outcomes.

The Indegene and Amwell technology collaboration will enable life sciences firms to enhance their patient support capabilities and engage with patients across digital, virtual, and physical channels. Indegene will be able to integrate Amwell's digital care platform, Converge, into its end-to-end patient support system, enabling life sciences firms to deliver a tailored care approach.

"Patient needs are rapidly evolving, and life sciences organizations often struggle to provide customized solutions that cater to them. By partnering with Amwell, we hope to equip life sciences organizations with customized patient engagement solutions that boost access to cutting-edge treatments and improve health outcomes," comments Nitin Raizada, Vice President, Enterprise Commercial at Indegene.

This collaboration will enable Indegene to enable life sciences firms to promote longitudinal care, behavioral health, and other specialty and chronic care sectors through virtual care automation and patient companionship. It will assist patients in gaining access to necessary treatments and receiving ongoing support to maintain adherence throughout their health journeys.

“As the future of care becomes increasingly hybrid, we are excited to partner with Indegene to further expand access to our Amwell Converge Platform and help accelerate their path to market with access to our installed base of payer and provider customers,” states Rene Barron, VP Channel Management, Amwell. “Together with Indegene, we aim to ensure that all life sciences organizations can more easily connect patients to quality care to improve clinical and financial outcomes, as well as delight patients with personalized care experiences.”

Weekly Brief